cytarabine has been researched along with Kaposi Sarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, SJ; Gruffaz, M; Jung, JU; Lu, C; Michael, QL; Rushing, T; Vasan, K; Zhou, S | 1 |
Busam, KJ; Dickson, MA; Geller, S; Myskowski, PL | 1 |
2 other study(ies) available for cytarabine and Kaposi Sarcoma
Article | Year |
---|---|
Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Topics: Animals; Antigens, Viral; Antiviral Agents; Apoptosis; Cell Line, Tumor; Cytarabine; DNA Replication; Female; Herpesvirus 8, Human; Humans; Lymphoma, Primary Effusion; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Sarcoma, Kaposi; Virus Latency; Virus Replication | 2018 |
Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Mantle-Cell; Male; Middle Aged; Oxaliplatin; Rituximab; Sarcoma, Kaposi; Transplantation, Autologous | 2018 |